. Author manuscript; available in PMC: 2015 Sep 14.

Published in final edited form as: Gynecol Oncol. 2010 Aug 14;119(2):237–242. doi: 10.1016/j.ygyno.2010.07.004

Table 3.

Model validation results – prevalence of CIN 2,3 and invasive cervical cancer among women screened using LBC every 2 years^*

Parameter	Data from:		Source
Parameter	Literature	Model	Source
Prevalence of CIN 1 cases among patients with HR HPV infection (%)	14	13	Herrero (2005)
Prevalence of CIN 2,3 cases among patients with HR HPV infection (%)	4	4.5	Khan (2005)
CIN 2,3 cases caused by HPV-16 (%)	41	43	Khan (2005)
CIN 2,3 cases caused by HPV-18 (%)	10	10	Khan (2005)
CIN 2,3 cases caused by non 16/18 HR HPV (%)	49	47	Khan (2005)
Annual incidence of cervical cancer in the United States (per 100,000 women)	9.4	9.2	Saraiya (2007)

CIN denotes cervical intraepithelial neoplasia, HR high-risk, and HPV human papillomavirus.